Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response

Archivum Immunologiae et Therapiae Experimentalis - Switzerland
doi 10.1007/s00005-016-0404-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Metallothionein-1 Suppresses Rheumatoid Arthritis Pathogenesis by Shifting the Th17/Treg Balance

European Journal of Immunology
AllergyImmunology
2018English

Suberoylanilide Hydroxamic Acid Attenuates Autoimmune Arthritis by Suppressing Th17 Cells Through NR1D1 Inhibition

Mediators of Inflammation
ImmunologyCell Biology
2019English

Rheumatoid Arthritis Bone Marrow Environment Supports Th17 Response

Arthritis Research & Therapy
2017English

Ssu72 Attenuates Autoimmune Arthritis via Targeting of STAT3 Signaling and Th17 Activation

Scientific Reports
Multidisciplinary
2017English

Bilirubin Suppresses Th17 Immunity in Colitis by Upregulating CD39

JCI insight
Medicine
2017English

Metformin Attenuates Experimental Autoimmune Arthritis Through Reciprocal Regulation of Th17/Treg Balance and Osteoclastogenesis

Mediators of Inflammation
ImmunologyCell Biology
2014English

Aldosterone Promotes Autoimmune Damage by Enhancing Th17-Mediated Immunity

Journal of Immunology
AllergyImmunology
2009English

Gut Microbiota Regulates K/BxN Autoimmune Arthritis Through Follicular Helper T but Not Th17 Cells

Journal of Immunology
AllergyImmunology
2016English

Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy